Stockreport

Histogen to Present at the Canaccord Genuity 40th Annual Growth Conference

Histogen Inc.  (HSTO) 
PDF SAN DIEGO, July 29, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restora [Read more]